HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2022 Sep 13

PMID 36098735

Authors

Matthew J Feinstein

Affiliations

Soon will be listed here.

Citing Articles

DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.

Woods J, Sokhela S, Akpomiemie G, Bosch B, Moller K, Bhaskar E HIV Med. 2024; 26(1):81-96.

PMID: 39286902 PMC: 11725414. DOI: 10.1111/hiv.13711.

Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study.

Madlala H, Myer L, Jao J, Geffen H, Matjila M, Fisher A J Int AIDS Soc. 2024; 27(6):e26313.

PMID: 38926935 PMC: 11208166. DOI: 10.1002/jia2.26313.

Causes of Chronic Kidney Disease and Their Associations with Cardiovascular Risk and Disease in a Sub-Saharan Low-Income Population.

Twala N, Tade G, Dessein P, Teckie G Int J Nephrol Renovasc Dis. 2024; 17:175-195.

PMID: 38882658 PMC: 11180468. DOI: 10.2147/IJNRD.S463751.

High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.

Mabhida S, Mchiza Z, Mokgalaboni K, Hanser S, Choshi J, Mokoena H BMC Infect Dis. 2024; 24(1):160.

PMID: 38308222 PMC: 10838000. DOI: 10.1186/s12879-024-09050-4.

Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.

Nazari I, Feinstein M Clin Microbiol Rev. 2024; 37(1):e0009822.

PMID: 38299802 PMC: 10938901. DOI: 10.1128/cmr.00098-22.

References

Feinstein M, Steverson A, Ning H, Pawlowski A, Schneider D, Ahmad F . Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women. J Am Heart Assoc. 2018; 7(21):e009985. PMC: 6404176. DOI: 10.1161/JAHA.118.009985. View

Barnett C, Hsue P . Human immunodeficiency virus-associated pulmonary arterial hypertension. Clin Chest Med. 2013; 34(2):283-92. PMC: 3749917. DOI: 10.1016/j.ccm.2013.01.009. View

Hudson J, Majonga E, Ferrand R, Perel P, Alam S, Shah A . Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review. JAMA. 2022; 328(10):951-962. PMC: 9471974. DOI: 10.1001/jama.2022.15078. View

Drozd D, Kitahata M, Althoff K, Zhang J, Gange S, Napravnik S . Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr. 2017; 75(5):568-576. PMC: 5522001. DOI: 10.1097/QAI.0000000000001450. View

Thompson M, Horberg M, Agwu A, Colasanti J, Jain M, Short W . Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2020; 73(11):e3572-e3605. DOI: 10.1093/cid/ciaa1391. View

Shah A, Stelzle D, Lee K, Beck E, Alam S, Clifford S . Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018; 138(11):1100-1112. PMC: 6221183. DOI: 10.1161/CIRCULATIONAHA.117.033369. View

Tarr P, Ledergerber B, Calmy A, Doco-Lecompte T, Marzel A, Weber R . Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons. Eur Heart J. 2018; 39(23):2147-2154. DOI: 10.1093/eurheartj/ehy163. View

Freiberg M, Chang C, Skanderson M, Patterson O, DuVall S, Brandt C . Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study. JAMA Cardiol. 2017; 2(5):536-546. PMC: 5541383. DOI: 10.1001/jamacardio.2017.0264. View

Freiberg M, Chang C, Kuller L, Skanderson M, Lowy E, Kraemer K . HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013; 173(8):614-22. PMC: 4766798. DOI: 10.1001/jamainternmed.2013.3728. View

10.

Feinstein M, Hsue P, Benjamin L, Bloomfield G, Currier J, Freiberg M . Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(2):e98-e124. PMC: 7993364. DOI: 10.1161/CIR.0000000000000695. View

11.

Post W, Budoff M, Kingsley L, Palella Jr F, Witt M, Li X . Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014; 160(7):458-67. PMC: 4143766. DOI: 10.7326/M13-1754. View

12.

Silverberg M, Leyden W, Xu L, Horberg M, Chao C, Towner W . Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014; 65(2):160-6. DOI: 10.1097/QAI.0000000000000009. View

13.

Smit M, van Zoest R, Nichols B, Vaartjes I, Smit C, Van Der Valk M . Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study. Clin Infect Dis. 2017; 66(5):743-750. PMC: 5850014. DOI: 10.1093/cid/cix858. View

14.

Tseng Z, Moffatt E, Kim A, Vittinghoff E, Ursell P, Connolly A . Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV. N Engl J Med. 2021; 384(24):2306-2316. PMC: 8415173. DOI: 10.1056/NEJMoa1914279. View